PHE has undertaken assessments of inactivation methods against SARS-CoV-2 with further evaluations ongoing. Category: UncategorisedBy 4 May 2021Leave a commentPost navigationPreviousPrevious post:Press release: Government to launch 40,000 person daily contact testing studyNextNext post:Research: Notifiable diseases: causative agents report for 2021